← Ranking

ARM · ARM HOLDINGS PLC /UK

Changes to watch · 7 concrete new risks (customers and competition, technology and products, tariffs and trade)

20-F 2026-05-26 ↗ compared with the previous 20-F 20-F 2025-05-28 ↗

Closing price50-day average200-day average

Technical events and factor profile →

Summary

Arm Holdings Plc /Uk adds risks from US tariffs and expanded Section 232 regulations, and warns of product liability and warranty claims due to manufacturing production silicon.

Automatic summary generated from the filing; it may contain inaccuracies.
Concrete new risks
7
Generic new risks
2
Filing
20-F · 2026-05-26

How the stock reacted

After the 20-F1 session5 sessions20 sessions
ARM+4.8%+33.4%+19.5%
Nasdaq-100 (QQQ)+1.8%+3.5%-0.4%
Difference+3.0%+29.9%+20.0%

From the close before the filing. Historical data, not a prediction.

What the concrete new risks are about

Customers and competition · 2Technology and products · 2Tariffs and trade · 1Supply chain · 1Litigation · 1

New risks 9

Concrete fact Tariffs and trade
US government launches Section 301 investigation into semiconductors

Further, BIS initiated a Section 232 investigation in 2025 into the effects of U.S. national security of imports of, among other things, semiconductors and semiconductor manufacturing equipment. The investigation resulted in an announcement of tariffs, effective January 15, 2026, applicable to NVIDIA H200 and AMD MI325X chips and systems incorporating such chips.

8 more new risks

With Pro you see every new risk in each filing, with concrete facts separated from generic wording, and the filing history.

Go Pro

Already Pro? Log in

Key figures quarterly · USD

Revenue (TTM)
$5.2B
YoY growth
+22.4%
Operating margin
7.1%
Cash / debt
$3.1B / —
Jun 26Mar 26Dec 25Sep 25Jun 25
Revenue$1.3B$1.5B$1.2B$1.1B$1.1B
YoY growth+22.4%+20.1%+26.3%+34.5%+12.1%
Gross margin97.2%97.9%97.6%97.4%97.2%
Operating margin7.1%29.4%14.9%14.4%10.8%
Net income$270M$313M$223M$238M$130M
Diluted EPS0.250.300.210.220.12

XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.

Factor profile percentile vs. the S&P 500 and the Nasdaq-100

Momentum
12 months excl. last: +55.2% · 6 months +36.6%
90
Trend quality
R² 0.01 · rising
46
Relative strength
+26.5% vs. the S&P 500 over 6 months
93
Volatility
83% annualised
98
Beta
beta 3.38
99
Distance from high
-48.2% from the 52-week high
5
Extension
-1.9 standard deviations from its 20-day average
10

0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors

Management tone MD&A

+6

Similar than in the previous 20-F (2025-05-28: +3, +2 points)

20-F of 2026-05-26 · 17.0% positive sentences, 11.2% negative · 347 sentences analysed

Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.

Top funds 13F

Duquesne Family Office · Stanley Druckenmiller
held since Q1 2026
0.2% $10.0M -74%
Bridgewater Associates · Ray Dalio
held since Q4 2025
0.0% $1.7M -99%

Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.

Insiders · last 90 days

Buys
—
Discretionary sells
—
10b5-1 plan sells
$3.1M
2026-09-21 Child Jason · CFO Sell (10b5-1 plan) $3.1M SEC ↗

Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.